跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SYNJARDY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SYNJARDY
Authorized
STANDARD
SYNJARDY
boehringer ingelheim (canada) ltd ltee
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a70049feb08fd874
Company
boehringer ingelheim (canada) ltd ltee
Type
Standard
Approval Details
Approval Id
a70049feb08fd874
Drug Approval Canada Name
SYNJARDY
Product Name
SYNJARDY
Status
Marketed
Status Date
2016-08-03
Original Market Date
2016-08-03
Din
02456613
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.18
Atc Original
A10BD20 METFORMIN AND EMPAGLIFLOZIN
Atc Name
a 10 bd 20
Aig Number
0258370005
Company Name
boehringer ingelheim (canada) ltd ltee
Company Address
5180 South Service Road, Burlington, Ontario, Canada, L7L 5H4
Active Ingredients
METFORMIN HYDROCHLORIDE
850 MG
EMPAGLIFLOZIN
12.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a70049feb08fd874
Type
Standard
Back to Health Canada Approvals